Publications

Representative Publications

April 2004 - January 2010

  • Clouser MC, Roe DJ, Foote JA, Harris RB. Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial. Pharmacoepidemiol Drug Safety 18(4):276-283, 2009. PMID:19226541
  • Algotar AM, Thompson PA, Ranger-Moore J, Stratton MS, Hsu C-H, Ahmann FR, Nagle RB, Stratton SP. Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity. Prostate 2010 Feb 4. (Epub ahead of print.) PMID:20135645
  • Clouser MC, Roe DJ, Foote JA, Harris RB. Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial. Pharmacoepidemiol Drug Safety 18(4):276-283, 2009. PMID:19226541
  • Foote JA, Ranger-Moore JR, Einspahr JG, Saboda K, Kenyon J. Warneke J. Miller RC, Goldman R. Xu MJ,Roe DJ, Alberts DS. Chemoprevention of human actinic keratoses by topical DL-alpha cocopherol. Cancer Prev Res 2(4):394-400, 2009. PMID:19336724
  • Hsu C-H, Long Q, Alberts DS. Estimation of colorectal adenoma recurrence with dependent censoring. BMC Med Res Methodol 9:66, 2009. PMID:19788750.
  • Hsu C-H, Taylor JMG. Nonparametric comparison of two survival distributions with dependent censoring via nonparametric multiple imputation. Statistics Medicine 28:462-475, 2009.
  • Hsu C-H, Taylor JMG, Long Q, Alberts DS. Analysis of colorectal adenoma recurrence data subject to informative censoring. Cancer Epidemiol Biomarkers Preven 18 (3):712-717, 2009. PMID:19240239
  • Hsu C-H. Evaluating potential benefits of dose-exposure response modeling for dose finding. Pharm Stat 8(3):203-15, 2009. PMID:19629954
  • Komenaka IK, Torabi R, Nair RG, Jayaram L, Hsu C-H, Bouton ME, Dave H, Hobohm DW. Intraoperative touch imprint and frozen section analysis of sentinel lymph nodes after neoadjuvantchemotherapy for breast cancer. Annals Surgery 251: 319-322, 2010. PMID:19864940.
  • Koreishi AF, Saenz AJ, Persky DO, Cui H, Moskowitz a, Moskowitz CH, Teruya-Feldstein J. The Role ofCytotoxic and regulatory T cells in relapsed/refractory Hodgkin lymphoma. Appl Immunohistochem Mol Morphol 2009 Dec 30 (Epub ahead of print) PMID:20065852
  • Persky DO, Moskowitz CH, Filatov A, Saxena R, Cui H, Teruya-Feldstein J. High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed/refractory Hodgkin lymphoma. Applied Immunohistochem Mol Morphol 18(1):35-40, 2010. PMID:19701081
  • Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Can Res 69(6):2260-2268, 2009. PMID:19276390
  • Stratton SP, Alberts DS, Einspahr JG, Sagerman PM, Warneke JA, Curiel CN, Myrdal PB, Nickoloff B, Brooks C, Saboda K, Yozwiak MI, Krutzsch MF, Hu C, Bowden, GT, Bartels PH. A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer. Cancer Prev Res, 3(2):160-9, 2010. PMID: 20103724. Epub 2010 Jan 26.
  • Thompson PA, Wertheim BC, Roe DJ, Ashbeck EL, Jacobs ET, Lance P, Martinez ME, Alberts DS. Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients. Cancer Prev Res 2(12):1023-30, 2009. Epub 2009 Dec 1. PMID:19952360
  • Thompson PA, Hsu C-H, Green S, Stopeck AT, Johnson K, Alberts DS, Chow HH. Sulindac and sulindacmetabolites in nipple aspirate fluid and effect on drug targets in a Phase I trial. Cancer Prev Res 3(1):101-7, 2010. PMID:20051377
  • Wertheim BC, Martinez ME, Ashbeck EL, Roe DJ, Jacobs ET, Alberts DS, Thompson PA. Physical activity as a determinant of fecal bile acid levels. Can Epidemiol, Biomarkers & Prevention 18:1591-1598, 2009.PMID:19383885

2006  

  • Baker AF, Dragovich T, Tate WR, Ramanathan RK, Roe D, Hsu CH, Kirkpatrick DL, Powis G: The antitumor thioredoxin-1 inhibitor PX-12 decreases thioredoxin-1 and VEGF levels in cancer patient plasma. J Lab Clin Med 147: 83-90, 2006.
  • Correlation of P53 expression and 14-3-3 expression, Haiyan Cui, January 2006.
  • Effect of Paclitaxel, Triacetin and ultrasound on tumor growth, Sylvia Brown, January 2006.
  • Effect of Bleomycin on histology scores in skin, Haiyan Cui, January 2006.
  • Gabayan AJ, Green SB, Sanan A, Jenrette J, Schultz C, Papagikos M, et al: GliaSite brachytherapy for treatment of recurrent malignant gliomas: A retrospective multi-institutional analysis. Neurosurgery 58: 701-709, 2006.
  • Kwei KA, Finch JS, Ranger-Moore J, Bowden GT: The role of Rac1 in maintaining malignant phenotype of mouse skin tumor cells. Cancer Lett 231: 326-338, 2006.
  • Yerushalmi HF, Besselsen DG, Ignatenko NA, Blohm-Mangone KA, Padilla-Torres JL, Stringer DE, Cui H, Holubec H, Payne CM, Gerner EW: The role of NO syntheses in arginine-dependent small intestinal and colonic carcinogenesis. Mol Carcinog 45: 93-105, 2006.

2005

  • Alberts DS, Martínez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, Lance P, and the Phoenix & Tucson Gastroenterologist Networks: Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 97: 846-853, 2005.
  • Buschhorn HM, Klein RR, Chambers SM, Hardy MC, Green S, Bearss D, Nagle RB: Aurora-A over-expression in high-grade PIN lesions and prostate cancer. The Prostate 64: 341-346, 2005.
  • Chen Z, Bassford T, Green SB, Cauley JA, Jackson RD, LaCroix AZ, Leboff M, Stefanick ML, Margolis KL: Postmenopausal hormone therapy and body composition--a substudy of the estrogen plus progestin trial of the Women's Health Initiative. Am J Clin Nutr 82: 651-656, 2005.
  • Chow HH, Hakim IA, Vining DR, Crowell JA, Ranger-Moore J, Chew WM, Celaya CA, Rodney SR, Hara Y, Alberts DS: Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 11 :4627-4633, 2005.
  • Frank DH, Davis JR, Ranger-Moore J, Liu Y, Bartels HG, Alberts DS, Bartels PH: Karyometry of infiltrating breast lesions. Anal Quant Cytol Histol 27: 195-201, 2005.
  • Hsu C-H: Joint modeling of recurrence and progression of adenoma polyps: A latent variable approach. Statistical Modeling 5:1-15, 2005.
  • Hsu, C-H: Joint modeling of recurrence and progression of adenomas: a latent variable approach. Statistical Modeling 5: 201-215, 2005.
  • List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D, Rimsza L, Heaton R, Knight R, Zeldis JB: Efficacy of lenalidomide in myelodysplastic syndromes. New Engl J Med 352:549-557, 2005.
  • Morse DL, Carroll D, Weberg L, Borgstrom MC, Ranger-Moore J, Gillies RJ: Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction. Anal Biochem 342: 69-77, 2005.
  • Payne CM, Holubec H, Bernstein C, Bernstein H, Dvorak K, Green SB, et al: Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk. Cancer Epidemiol Biomarkers Prev 14: 2066-2075, 2005.
  • Payne CM, Holubec H, Bernstein C, Bernstein H, Dvorak K, Green SB, et al: Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk. Cancer Epidemiol Biomarkers Prev 14: 2066-2075, 2005.
  • Ranger-Moore J, Alberts DS, Montironi R, Garcia F, Davis J, Frank D, Brewer M, Mariuzzi GM, Bartels HG, Bartels PH: Karyometry in the early detection and chemoprevention of intraepithelial lesions. Eur J Cancer 41: 1875-1888, 2005.
  • Ranger-Moore J, Frank D, Lance P, Alberts D, Yozwiak M, Bartels HG, Einspahr J, Bartels PH: Karyometry in rectal mucosa of patients with previous colorectal adenomas. Anal Quant Cytol Histol 27: 134-142, 2005.
  • Summary of DFMO/Triamcinolone Study, Kathy Saboda, December 2005.

2004

  • Alberts D, Ranger-Moore J, Einspahr J, Saboda K, Bozzo P, Liu Y, Xu X-C, Lotan R, Warneke J, Salasche S, Stratton S, Levine N, Goldman R, Islas M, Duckett L, Thompson D, Bartels P: Safety and efficacy of dose-intensive oral vitamin A in subjects with sun-damaged skin. Cl Can Res 10:1875-1880, 2004.
  • Chen Z, Stini WA, Marshall JR, Martinez ME, Guillen-Rodriguez JM, Roe D, Alberts DS: Wheat bran fiber supplementation and bone loss among older people. Nutrition 20:747-751, 2004.
  • Dvorakova K, Payne CM, Ramsey L. Holubec H, Sampliner R, Dominguez J, Dvorak B, Bernstein H, Bernstein C, Prasad A, Fass R, Cui H, Garewal H: Increased expression and secretion of interleukin-6 in patients with Barrett’s esophagus. Clin Cancer Res. 10:2020-8, 2004.
  • Garcia FA, Ranger-Moore J, Barker B, Davis J, Brewer M, Lozevski J, Vinyak S, Liu Y, Yemane J, Hatch KD, Alberts DS, Bartels HG, Bartels PH: Karyometric image analysis for intraepithelial and invasive cervical lesions. Anal Quant Cytol Histopathol. 26(3):141-50, 2004.
  • Hess LM, Krutzsch MF, Guillen J, Chow H-HS, Einspahr J, Batta AK, Salen G, Reid ME, Earnest DL, Alberts DS: Results of a Phase I multiple-dose clinical study of ursodeoxycholic acid. Cancer Epidemiol Biomarkers Prev. 13:861-867, 2004.
  • Jacobs ET, Giuliano AR, Roe DJ, Guillen-Rodriquez JM, Hartz VL, Whitacre RC, Alberts DS, Martinez ME: Dietary change in an intervention trial of wheat bran fiber and colorectal adenoma recurrence. Annals of Epidemiology 14:280-286, 2004.
  • Ranger-Moore J, Bartels PH, Thompson D, Bozzo P, Einspahr J, Liu Y, Saboda KL, Duckett L, Alberts DS: Karyometric analysis of actinic damage in unexposed and sun-exposed skin, and in actinic keratoses in untreated individuals. Anal Quant Cytol Histopathol. 26(3):155-65, 2004.
  • Staten LK, Gregory-Mercado KY, Ranger-Moore J, Will JC, Giuliano AR, Ford ES, Marshall J: Provider counseling, health education and community health workers: the Arizona WISEWOMAN Project. J Women’s Health 13(5):547-556, 2004.
  • Theilmann RJ, Borders R, Trouard TP, Xia G, Outwater E, Ranger-Moore J, Gillies RJ, Stopeck A: Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 6:831-837, 2004.